The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(3-((6-(3-fluorophenoxy)pyridin-3-yl)methyl)isoxazol-5-yl)pyridin-2-amine ID: ALA4538831
PubChem CID: 59255347
Max Phase: Preclinical
Molecular Formula: C20H15FN4O2
Molecular Weight: 362.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncccc1-c1cc(Cc2ccc(Oc3cccc(F)c3)nc2)no1
Standard InChI: InChI=1S/C20H15FN4O2/c21-14-3-1-4-16(10-14)26-19-7-6-13(12-24-19)9-15-11-18(27-25-15)17-5-2-8-23-20(17)22/h1-8,10-12H,9H2,(H2,22,23)
Standard InChI Key: OUKYASALCUMUSZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
23.6476 -21.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6465 -22.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3545 -22.8386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0642 -22.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0613 -21.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3527 -21.2013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7725 -22.8367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7671 -21.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5149 -21.5223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0594 -20.9130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6481 -20.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8495 -20.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9776 -19.4589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7900 -19.3704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2694 -20.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0811 -19.9438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4113 -19.1953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9238 -18.5342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1139 -18.6257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2236 -19.1057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.5521 -18.3575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3623 -18.2732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6909 -17.5258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2069 -16.8662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3908 -16.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0660 -17.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5032 -17.4366 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 2 0
5 8 1 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
23 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.36Molecular Weight (Monoisotopic): 362.1179AlogP: 4.24#Rotatable Bonds: 5Polar Surface Area: 87.06Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.87CX LogP: 3.44CX LogD: 3.43Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -1.69
References 1. Trzoss M, Covel JA, Kapoor M, Moloney MK, Soltow QA, Webb PJ, Shaw KJ.. (2019) Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp., 29 (23): [PMID:31668974 ] [10.1016/j.bmcl.2019.126713 ]